The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avastin was produced by Roche.
Safety for both Tecentriq and Avastin was reportedly consistent with the known safety profile of each medicine and with the underlying disease. ... With Tecentriq plus Avastin already a standard of care in unresectable HCC, we are pleased with the
been ‘measured in tone’ in their comments about Avastin’s use in AMD. ... The court also ruled that Roche’s refusal to supply samples of Avastin for a comparator clinical trial could not have had an anti-competitive effect.
Tecentriq in combination with Avastin significantly improved recurrence-free survival. Genentech – a member of the Roche group – has announced that its phase 3 study of Tecentriq (atezolizumab) combination mets its primary ... Safety for both
of FRα and who had been treated with one to three prior systemic treatment regimens – at least one of which included Avastin (bevacizumab).
The biosimilar to Genentech's Avastin was found to be highly similar to the reference product. ... Vegzelma is a recombinant humanised monoclonal antibody treatment biosimilar to Genentech's Avastin (bevacizumab), which is approved in the EU.
No results were found
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...